Publication

Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia

Giles, Francis
; 
Rizzieri, David
; 
Ravandi, Farhad
; 
Swords, Ronan
; 
Jacobsen, Tove Flem
; 
O’Brien, Susan
Identifiers
http://hdl.handle.net/10379/11635
 https://doi.org/10.13025/26701
Publication Date
2012-04-01
Keywords
Type
Article
Downloads
Show all metadata
Citation
Giles, Francis; Rizzieri, David; Ravandi, Farhad; Swords, Ronan; Jacobsen, Tove Flem; O’Brien, Susan (2012). Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia. Leukemia Research 36 (4), E71-E73
Abstract
Funder
Publisher
Elsevier BV
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland
cbn
Collections
Externally hosted open access publications with University of Galway authors (2)